en

PRODUCT DETAIL

Yesintek 90 mg injekčný roztok v naplnenej injekčnej striekačke

Code 9072E
MA number EU/1/24/1892/003
Product Form: sol inj 1x1 ml/90 mg (striek.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Biosimilar Collaborations Ireland Limited, Ireland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC05 Ustekinumab
Shelf life: 18
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 14.02.2025
Validity: 14.02.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.02.2025
eu-flag.png sk-flag.png